Skip to main content

Table 3 Factors associated with blood pressure control

From: Hypertension control and care at Mulago Hospital ambulatory clinic, Kampala-Uganda

Variable

Controlled blood pressure

Uncontrolled blood pressure

Odds ratio

p value

Adjusted odds ratio

p value

Age

61 (51–71)

59 (50–70)

1.01 (1.00–1.02)

0.195

  

Gender—female

182 (91.9)

460 (84.7)

2.05 (1.17–3.60)

0.012

1.85 (1.03–3.34)

0.04

ARBs

78 (39.4)

232 (42.7)

0.87 (0.63–1.21)

0.416

  

ACEi

55 (27.8)

201 (37.0)

0.65 (0.46–0.93)

0.02

0.53 (0.36–0.78)

0.001

Beta blockers

94 (47.5)

293 (54.0)

0.77 (0.56–0.83)

0.118

0.62 (0.44–0.88)

0.008

Calcium channel blockers

127 (64.1)

409 (75.3)

0.58 (0.41–0.83)

0.003

0.54 (0.37–0.78)

0.002

Centrally acting

5 (2.53)

31 (5.71)

0.43 (0.16–1.12)

0.083

0.36 (0.13–0.98)

0.046

Thiazide diuretic

120 (60.6)

388 (71.5)

0.61 (0.44–0.86)

0.005

0.54 (0.38–0.78)

0.001

Potassium sparing

9 (4.55)

15 (2.76)

1.67 (0.72–3.89)

0.23

  

Number of anti-hypertensive drugs

 One

20 (10.1)

22 (4.1)

[1]

   

 Two

82 (41.4)

154 (28.4)

0.59 (0.30–1.14)

0.113

  

 Three

69 (34.9)

239 (44.0)

0.32 (0.16–0.62)

0.001

  

 Four

18 (9.1)

116 (21.4)

0.17 (0.08–0.37)

<0.001

  

 Five

5 (2.5)

9 (1.7)

0.61 (0.18–2.13)

0.44

  

 Having all investigations

24 (12.1)

79 (14.5)

0.81 (0.50–1.32)

0.399

  

 Having any comorbidity

25 (12.6)

65 (12.0)

1.06 (0.65–1.74)

0.809

  

 Keeping appointment

94 (48.2)

252 (47.5)

1.03 (0.74–1.43)

0.858

  
  1. ARBs angiotensin receptor blockers, ACEi angiotensin converting enzyme inhibitor